Acyclovir halts progression of herpes zoster in immunocompromised patients.
about
The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic InfectionsEfficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic reviewRecommendations for the Management of Herpes ZosterAcyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokineticsCutaneous adverse reactions to acyclovir: case reportsContralateral hemiparesis following herpes zoster ophthalmicus.Treatment of peripheral neuropathiesGuidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerSorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes ZosNovel agents for the therapy of varicella-zoster virus infections.Effectiveness of intravenous acyclovir in immunocompetent patient with herpes zoster encephalitisClinical practice: Herpes zosterPractice guidelines for the diagnosis and management of skin and soft-tissue infections.Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.Antiviral therapy: current concepts and practicesThe prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantationUse of murine monoclonal antibodies for laboratory diagnosis of varicella-zoster virus infectionPharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infectionEye and Periocular Skin Involvement in Herpes Zoster InfectionVaricella zoster: an update on current treatment options and future perspectives.Design and development of antivirals and intervention strategies against human herpesviruses using high-throughput approach.European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.The effects of famciclovir and epidural block in the treatment of herpes zoster.Herpes zoster associated encephalitis: clinical findings and acyclovir treatment.Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment.Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions.[Diagnostics and management of herpes zoster ophthalmicus].A randomized double-blind placebo controlled trial of oral acyclovir in renal allograft recipients.Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications.Comparison of techniques and evaluation of three commercial monoclonal antibodies for laboratory diagnosis of varicella-zoster virus in mucocutaneous specimens.Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment.Viral infections in leukemia and bone marrow transplant patients.Ophthalmic herpes zoster.Clinical use of acyclovirApproches actuelles au traitement du zona: Aspects controversés du traitement du zona.A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.Antiviral therapy. New drugs and their uses.Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome.Drug eruption secondary to aciclovir with recall phenomenon in a dermatome previously affected by herpes zoster.
P2860
Q26751038-6EEC673F-FEF0-4747-AC87-5BCE64292B8CQ26849607-F662DA6B-FE49-4884-B6F7-69C28A8542D8Q28315869-A45B6F55-A79D-4693-97D0-25A33E3E3D55Q28353263-762D6936-A62A-465E-BB50-E86FB102C4C5Q33582636-F96B2301-281C-45C8-953A-8140726B89EAQ33620963-F7E1BDB2-5D7E-48F2-B49C-D8A08E2D2002Q33621708-C5640862-E41C-4E1D-BA9B-21D6DBD61675Q33650105-598B8AE0-3E94-4953-A2ED-F0A8FFB0B545Q33695355-2E0D417B-4D53-4AA2-AF23-992E8ECC3CA3Q34074994-5A216F61-8947-4F6F-829D-21F9D705CF1CQ34290634-8D273380-A17B-42AA-8944-7E2B90D589FFQ34358014-313371CC-1625-4E53-A577-9A501F39140BQ34460523-C1F829BC-4437-4955-B89F-4CBCAAF6821DQ35121549-73949CD2-4E27-4C68-BEB0-8B0B55FBF946Q35541334-CA34374C-4E35-416D-9E84-4B839A5FCECCQ36070394-E1F9ED7F-8A02-416D-ABA7-26E2DA0ADAC3Q36467322-DF71B801-BE2F-4519-85F8-067FB78688A9Q37153278-6651EBB2-5B03-4C28-A908-170A825D26C7Q37190818-43A7B114-35A6-49DA-99A3-C308B232F5BAQ37380047-AB68262B-73AB-468D-AB88-312AAF576FF1Q38167380-D7CD5972-AB02-48BA-9E78-BBCF8645BA56Q38227257-FB3099D6-69E4-4D17-BB5E-39AA4D6BA468Q38942259-EB348E7E-0FE7-4360-B39C-B50D7E128067Q39416857-EE0CEBCE-E693-4AEA-92CC-5E67B3F1F96DQ39619869-D2F11301-D93F-4EA4-9A7F-790E68A70773Q39643357-357AD52D-3CA2-4981-862E-3191EF2E3DABQ40009156-B1400733-069C-4292-9F29-39E06C80C090Q40058091-C5849AB5-C16F-4060-86D8-AABF63CB1CD3Q40141163-AFF5960E-FB76-4031-A0ED-343CB877CB0FQ40164352-AD955358-5FF5-4460-BF52-10F8757C8FCCQ40180423-B6602D84-B5C1-4745-9CD4-5EFA5EFA9AD3Q40682805-467ED9C8-D040-49B3-951F-B43A6666AFA1Q40722959-87CBF199-1D3D-4E3E-865C-D5A6916C7CF3Q40773555-314453B4-395E-43EA-9236-0F25845A649EQ41946058-E980D0B8-D0FE-4A25-885C-05791149A823Q42079336-D240CB52-A0D0-424C-91EA-C11AEB79C7C5Q43567469-97D709FF-1C4D-4A6F-937A-E463C17474EAQ43669773-3934B933-AD1F-4DC2-B71A-4B536E1BE7DCQ43795029-7E4C90EF-699C-42F7-844C-AE2CCA7121E6Q43959022-28B2171D-C7A5-4293-BC1C-C298A9404A50
P2860
Acyclovir halts progression of herpes zoster in immunocompromised patients.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Acyclovir halts progression of herpes zoster in immunocompromised patients.
@en
Acyclovir halts progression of herpes zoster in immunocompromised patients.
@nl
type
label
Acyclovir halts progression of herpes zoster in immunocompromised patients.
@en
Acyclovir halts progression of herpes zoster in immunocompromised patients.
@nl
prefLabel
Acyclovir halts progression of herpes zoster in immunocompromised patients.
@en
Acyclovir halts progression of herpes zoster in immunocompromised patients.
@nl
P2093
P1476
Acyclovir halts progression of herpes zoster in immunocompromised patients.
@en
P2093
Ambinder RF
Balfour HH Jr
Segreti AC
P304
P356
10.1056/NEJM198306163082404
P407
P577
1983-06-01T00:00:00Z